相关实验视频

Updated: Jun 13, 2025

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

14.7K

埃克斯卡利伯-RRMM:在复发性/耐药性多发性骨髓瘤中对伊贝尔多米德,达拉图穆马布和德克萨米松进行III期试验

Sagar Lonial1, Meletios A Dimopoulos2,3, Jesus G Berdeja4

  • 1Winship Cancer Institute, Emory University, Atlanta, GA, USA.

Future oncology (London, England)
|May 10, 2025
PubMed
概括

新型治疗方法,如伊伯多米德 (IBER),对复发性/耐药性多发性骨髓瘤 (RRMM) 显示出前景. 在EXCALIBER-RRMM试验中,评估IBER加上德甲和达拉图姆巴 (IberDd),以改善患者的治疗结果.

关键词:
这是CELMoD代理商.复发性/耐药性多发性骨髓瘤临床试验临床试验临床试验临床试验临床试验艾伯多胺是一种第三阶段第三阶段

更多相关视频

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.0K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.1K

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145